دورية أكاديمية
POSA61 Incremental Cost per Relapse Avoided of Ozanimod Compared with First-Line Disease-Modifying Therapies for Relapsing Forms of Multiple Sclerosis
| العنوان: | POSA61 Incremental Cost per Relapse Avoided of Ozanimod Compared with First-Line Disease-Modifying Therapies for Relapsing Forms of Multiple Sclerosis |
|---|---|
| المؤلفون: | Kantor, D, Pham, T, Patterson-Lomba, O, Swallow, E, Dua, A, Gupte-Singh, K |
| المصدر: | In Value in Health January 2022 25(1) Supplement:S45-S45 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2021.11.206 |